DuPont de Nemours, Inc.

Valuation Analysis

About the Company

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the com

DuPont de Nemours, Inc. Stock at a Glance

DuPont de Nemours, Inc. (DD) is currently trading at $48.26 with a market capitalization of $19.5B. The trailing P/E ratio stands at 127x, with a forward P/E of 18.44x. The 52-week range spans from $27.45 to $52.66; the current price is 8.4% below the yearly high. Year-over-year revenue growth stands at +4.3%.

💰 Dividend

DuPont de Nemours, Inc. pays an annual dividend of $0.80 per share, representing a yield of 1.66%. The payout ratio stands at 321.05%. The elevated payout ratio reflects a mature dividend policy.

📊 Analyst Rating

15 analysts rate DuPont de Nemours, Inc. (DD) on consensus: Strong Buy. The average price target is $57.07, implying +18.25% from the current price. Analyst price targets range from $52.00 to $64.00.

DuPont de Nemours, Inc.: The Investment Case in Detail

DuPont de Nemours, Inc. (DD) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Wall Street consensus sits at Strong Buy with an average price target implying roughly 18.25% upside from current levels — analyst sentiment is firmly constructive.

The Bear Case

Revenue growth has slowed to just 4.3%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion.

What to Watch Next

• The forward P/E of 18.44x is meaningfully below the trailing 127x — analysts expect earnings to step up; the next earnings release is the test.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to market-like volatility.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy DuPont de Nemours, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.